Literature DB >> 10376022

Outcomes of an educational-outreach service for community medical practitioners: non-steroidal anti-inflammatory drugs.

F W May1, D S Rowett, A L Gilbert, J I McNeece, E Hurley.   

Abstract

OBJECTIVE: Exploration of longer-term outcomes of an ongoing educational-outreach service for community doctors.
DESIGN: Quasi-experimental, with parallel and historical comparisons.
SETTING: Since 1992, a teaching-hospital-based service has been providing advice and information on drugs and therapeutic strategies to community medical practitioners. PARTICIPANTS: 210 doctors practising in a particular area of metropolitan Adelaide (79% general practitioners; 21% specialists).
INTERVENTIONS: Two surgery visits during 1992 focused on better use of prescribed non-steroidal anti-inflammatory drugs (NSAIDs). Subsequent visits on other topical therapeutic issues have occurred regularly. MAIN OUTCOME MEASURES: Doctor participation in the service; supply of prescription NSAIDs; hospital admissions for gastrointestinal (GI) effects of NSAID use.
RESULTS: 89% of doctors practising within the service area received the first visit on NSAIDs and 86% received the second visit. More than 85% continue to receive the service. Relative to a comparison area, aggregate reductions of 9% and 28%, respectively, were observed in two different measures of NSAID use. During an 11-year observation period, a single change point in the number of hospital admissions for GI disorders occurred in the service area, coinciding with delivery of the NSAID program. In the five years since the visits commenced, a 70% reduction in admissions was observed. No notable changes in hospital admission rates occurred in the comparison area.
CONCLUSIONS: A continuing education and support service for community medical practitioners which uses principally academic detailing methods in its contact with doctors has contributed to sustained changes in prescribed NSAID use over a five-year period. A focus on risk-minimisation in prescribing of NSAIDs appears to have contributed to reductions in hospitalisations for GI adverse events.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10376022

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  16 in total

1.  Safer medicines management in primary care.

Authors:  Anthony J Avery; Aziz Sheikh; Brian Hurwitz; Lesley Smeaton; Yen-Fu Chen; Rachel Howard; Judy Cantrill; Simon Royal
Journal:  Br J Gen Pract       Date:  2002-10       Impact factor: 5.386

Review 2.  Communication of medical product risk: how effective is effective enough?

Authors:  Stephen A Goldman
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

3.  National Prescribing Service: creating an implementation arm for national medicines policy.

Authors:  L M Weekes; J M Mackson; M Fitzgerald; S R Phillips
Journal:  Br J Clin Pharmacol       Date:  2005-01       Impact factor: 4.335

4.  Patient-specific academic detailing for smoking cessation: feasibility study.

Authors:  Margaret Jin; Antony Gagnon; Mitchell Levine; Lehana Thabane; Christine Rodriguez; Lisa Dolovich
Journal:  Can Fam Physician       Date:  2014-01       Impact factor: 3.275

5.  Musculoskeletal education in general practice: a questionnaire survey.

Authors:  E M Wise; D J Walker; D A Coady
Journal:  Clin Rheumatol       Date:  2014-02-08       Impact factor: 2.980

6.  Opioid analgesic prescribing and use - an audit of analgesic prescribing by general practitioners and The Multidisciplinary Pain Centre at Royal Brisbane Hospital.

Authors:  L M Nissen; S E Tett; T Cramond; B Williams; M T Smith
Journal:  Br J Clin Pharmacol       Date:  2001-12       Impact factor: 4.335

7.  Adverse drug reactions to antiretroviral therapy: prospective study in children in sikasso (mali).

Authors:  Aboubacar A Oumar; Korotoumou Diallo; Jean P Dembélé; Lassana Samaké; Issa Sidibé; Boubacar Togo; Mariam Sylla; Anatole Tounkara; Sounkalo Dao; Paul M Tulkens
Journal:  J Pediatr Pharmacol Ther       Date:  2012-10

8.  Development and Feasibility of an Academic Detailing Intervention to Improve Prescription Drug Monitoring Program Use Among Physicians.

Authors:  Kelly S Barth; Sarah Ball; Rachel S Adams; Ruslan Nikitin; Nikki R Wooten; Zaina P Qureshi; Mary J Larson
Journal:  J Contin Educ Health Prof       Date:  2017       Impact factor: 1.355

9.  Investigation into the reasons for preventable drug related admissions to a medical admissions unit: observational study.

Authors:  R L Howard; A J Avery; P D Howard; M Partridge
Journal:  Qual Saf Health Care       Date:  2003-08

10.  Protocol for the PINCER trial: a cluster randomised trial comparing the effectiveness of a pharmacist-led IT-based intervention with simple feedback in reducing rates of clinically important errors in medicines management in general practices.

Authors:  Anthony J Avery; Sarah Rodgers; Judith A Cantrill; Sarah Armstrong; Rachel Elliott; Rachel Howard; Denise Kendrick; Caroline J Morris; Scott A Murray; Robin J Prescott; Kathrin Cresswell; Aziz Sheikh
Journal:  Trials       Date:  2009-05-01       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.